Haemophilia

A case of three-year-old boy with severe haemophilia A on prophylaxis identified with a chronic subdural haematoma 2 years after the first episode of acute subdural bleeding
pp. e1-e2(2)
Authors: SAKATA, K.; MATSUMOTO, T.; WADA, H.; KUMAMOTO, T.; IWAMOTO, S.; OHISHI, K.; TAKAHASHI, J.; KATAYAMA, N.; KOMADA, Y.

Two <i>de novo</i> factor VIII gene mutations in the family of an isolated severe haemophilia A patient
pp. e3-e4(2)
Authors: KAPSIMALI, Z.; PAVLOVA, A.; PERGANTOU, H.; ADAMTZIKI, E.; OLDENBURG, J.; PLATOKOUKI, H.

Late avascular necrosis of the femoral head (anfh) after the percutaneous fixation of a non-displaced fracture of the femoral neck in a haemophilic patient with inhibitors: a non-reported association
pp. e4-e5(2)
Authors: RODRIGUEZ-MERCHAN, E. C.; GOMEZ-CARDERO, P.; JIMENEZ-YUSTE, V.

Further evidence of heterogeneity of gene defects in Italian families with factor XIII deficiency
pp. e6-e8(3)
Authors: CASTAMAN, G.; GIACOMELLI, S. H.; SCHROEDER, V.; SANNA, S.; VALDRÈ, L.; MORFINI, M.; BANOV, L.; KOHLER, H. P.; RODEGHIERO, F.

Diagnosis of type 1 vs. 2A and 2M von Willebrand disease
pp. e9-e11(3)
Author: FAVALORO, E. J.

Factor X deficiency and pregnancy: case report and counselling
pp. e11-e12(2)
Authors: TEIXEIRA, P. S.; OLIVEIRA, P. S.; GUERRA, J. C. C.; HAMERSCHLAK, N.; COLOMBINI, M. P; KALIL, R.

Heterotopic ossification in quadratus femoris muscle in a haemophilic patient
pp. e13-e14(2)
Authors: KALENDERER, O.; BOZOGLAN, M.; AGUS, H.

Liver transplantation in Spanish haemophiliacs
pp. e15-e16(2)
Authors: AZNAR, J. A.; MARCO, A.; PARRA, R.; JIMÉNEZ-YUSTE, V.; LUCÍA, F.; BALDA, I.; SOTO, I.

Clinical histories and molecular characterization of two afibrinogenemic patients: insights into clinical management
pp. e16-e18(3)
Authors: GRANDONE, E.; TISCIA, G.; CAPPUCCI, F.; FAVUZZI, G.; SANTACROCE, R.; PISANELLI, D.; SOLI, F.; LEGNANI, C.; RIZZO, M. A.; PALARETI, G.; MARGAGLIONE, M.

Early prophylaxis/FVIII tolerization regimen that avoids immunological danger signals is still effective in minimizing FVIII inhibitor developments in previously untreated patients - long-term follow-up and continuing experience
pp. e18-e20(3)
Authors: AUERSWALD, G.; BIDLINGMAIER, C.; KURNIK, K.

Off-pump myocardial revascularization in a patient with haemophilia A: a case report and operative strategies
pp. e20-e22(3)
Authors: SPRUNCK, A.; MAECHEL, A. L.; LEVY, F.; FARADJI, A.; STEIB, A.

Phenotypic variability in a family with haemophilia B and prothrombin G20210A
pp. e22-e23(2)
Authors: BELTRÁN-MIRANDA, C. P.; LUNA-ZÁIZAR, H.; LÓPEZ-JIMÉNEZ, J. J.; MANTILLA-CAPACHO, J. M.; LAFFAN, M.; JALOMA-CRUZ, A. R.

Spontaneous umbilical cord haematoma and congenital factor VII deficiency
pp. e24-e25(2)
Authors: JOUANNELLE, C.; GIANSILY-BLAIZOT, M.; MONPOUX, F.; CASAGRANDE, F.; POIRÉE, M.; BÉRARD, E.

Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII
pp. e25-e27(3)
Authors: TOKGOZ, H.; CALISKAN, U.; LAVIGNE-LISSALDE, G.; GIANSILY-BLAIZOT, M.

Treatment decisions and usage of clotting factor concentrate by a cohort of Indian haemophilia patients
pp. e27-e29(3)
Authors: DHARMARAJAN, S.; GUND, P.; PHADNIS, S.; LOHADE, S.; LALWANI, A.; KAR, A.

Acute alveolar haemorrhage in a patient with haemophilia B
pp. e29-e31(3)
Authors: SUZUKI, T.; YAMAMOTO, Y.; OTAKI, M.; SEITA, I.; HAGIWARA, T.; AMANO, K.; FUKUTAKE, K.

Acquired haemophilia in severe pelvic endometriosis: a new association?
pp. e31-e32(2)
Authors: FERRARI, A.; CONTE, E.; TROCCOLI, M. L.; NOBILI, F.; MARZIANI, R.; ROBERTI, C.; MOSSA, B.; MAZZUCCONI, M.; LUKIC, A.; MOSCARINI, M.

A family with type 2M VWD with normal VWF:RCo but reduced VWF:CB and a M1761K mutation in the A3 domain
pp. e33-e33(1)
Authors: KEELING, D.; BEAVIS, J.; MARR, R.; SUKHU, K.; BIGNELL, P.

Remission of acquired von Willebrand syndrome after successful treatment of gastric MALT lymphoma
pp. e34-e35(2)
Authors: BIONDO, F.; MATTURRO, A.; SANTORO, C.; LEPORACE, A.; D'ELIA, G.; BALDACCI, E.; PIGNOLONI, P.; PULSONI, A.; FOÀ, R.; MAZZUCCONI, M.

Does haemophilia protect against ischaemic cardiovascular disease?
pp. e35-e36(2)
Authors: FRANSEN VAN DE PUTTE, D. E.; FISCHER, K.; SCHUTGENS, R. E. G.; MAUSER-BUNSCHOTEN, E. P.

Factor V and FVIII deficiency in a young Czech woman
pp. e37-e37(1)
Authors: DULÍČEK, P.; PECKA, M.; MALÝ, J.

Management of bleeding in a child with haemophilia in Africa with freeze-dried plasma
pp. e38-e39(2)
Authors: MAURIN, O.; MARTINAUD, C.; BOULESTEIX, G.; EVE, O.; BERTANI, A.; GOUDARD, Y.; KAISER, E.

Pulmonary emboli in a patient with haemophilia: a case report
pp. e40-e41(2)
Authors: RASHIDI, A.; BHASIN, M.

Corrigendum
pp. e42-e42(1)

<i>Haemophilia</i> 2012
pp. 1-1(1)
Authors: Lee, Christine A.; Kessler, Craig; Makris, Mike; Gough, Samantha

Plagiarism and <i>Haemophilia</i>
pp. 2-2(1)
Authors: Makris, Mike; Kessler, Craig; Lee, Christine

Memories of my research into von Willebrand's disease
pp. 3-6(4)
Authors: BLOMBÄCK, M.

The Arosenius Fund
pp. 7-7(1)
Author: ASTERMARK, J.

Aspects of current management: orthopaedic surgery in haemophilia
pp. 8-16(9)
Author: RODRIGUEZ-MERCHAN, E. C.

HCV-related liver cancer in people with haemophilia
pp. 17-24(8)
Authors: MEIJER, K.; HAAGSMA, E. B.

A Systematic Review: The use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy
pp. 25-33(9)
Authors: TRIGG, D. E.; STERGIOTOU, I.; PEITSIDIS, P.; KADIR, R. A.

Central nervous system bleeding in patients with rare bleeding disorders
pp. 34-38(5)
Authors: SIBONI, S. M.; ZANON, E.; SOTTILOTTA, G.; CONSONNI, D.; CASTAMAN, G.; MIKOVIC, D.; BIONDO, F.; TAGLIAFERRI, A.; IORIO, A.; MANNUCCI, P. M.; PEYVANDI, F.

Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors
pp. 39-45(7)
Authors: ZANON, E.; IORIO, A.; ROCINO, A.; ARTONI, A.; SANTORO, R.; TAGLIAFERRI, A.; COPPOLA, A.; CASTAMAN, G.; MANNUCCI, P. M.; THE ITALIAN ASSOCIATION OF HEMOPHILIA CENTERScr10,

Factor IX replacement to cover total knee replacement surgery in haemophilia B: a single-centre experience, 2000-2010
pp. 46-49(4)
Authors: UPRICHARD, J.; ADAMIDOU, D.; GODDARD, N. J.; MANN, H. A.; YEE, T. T.

DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype
pp. 50-55(6)
Authors: SEARY, M. E.; FELDMAN, D.; CARCAO, M. D.

Web-enabled registry of inherited bleeding disorders in Portugal: conditions and perception of the patients
pp. 56-62(7)
Authors: TEIXEIRA, L.; FERREIRA, C.; SANTOS, B. S.; SAAVEDRA, V.

Survey of current prophylaxis practices and bleeding characteristics of children with severe haemophilia A in US haemophilia treatment centres
pp. 63-68(6)
Authors: RAGNI, M. V.; FOGARTY, P. J.; JOSEPHSON, N. C.; NEFF, A. T.; RAFFINI, L. J.; KESSLER, C. M.

Evaluation of bone mineral density in Turkish children with severe haemophilia A: Ankara hospital experience
pp. 69-74(6)
Authors: ALIOGLU, B.; SELVER, B.; OZSOY, H.; KOCA, G.; OZDEMIR, M.; DALLAR, Y.

Scuba diving is possible and safe for patients with haemophilia
pp. 75-79(5)
Authors: SCHVED, J. F.; DE HARO, M.; DRAPEAU, M.; SCHVED, M.

Haemophilia & Exercise Project (HEP): subjective and objective physical performance in adult haemophilia patients - results of a cross-sectional study
pp. 80-85(6)
Authors: CZEPA, D.; Von MACKENSEN, S.; HILBERG, T.

Clinical outcomes and patient satisfaction following total joint replacement in haemophilia - 23-year experience in knees, hips and elbows
pp. 86-93(8)
Authors: WANG, K.; STREET, A.; DOWRICK, A.; LIEW, S.

Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors - Phase I trial
pp. 94-101(8)
Authors: SHIRAHATA, A.; FUKUTAKE, K.; MIMAYA, J.; TAKAMATSU, J.; SHIMA, M.; HANABUSA, H.; TAKEDANI, H.; TAKASHIMA, Y.; MATSUSHITA, T.; TAWA, A.; HIGASA, S.; TAKATA, N.; SAKAI, M.; KAWAKAMI, K.; OHASHI, Y.; SAITO, H.

Approach to the treatment, characterization and diagnosis of an acquired auto-antibody directed against factors prothrombin, factor X and factor IX: a case report and review of the literature
pp. 102-107(6)
Authors: ROCHANDA, L.; Del ZOPPO, G. J.; FEINSTEIN, D. I.; LIEBMAN, H. A.

Safety and effectiveness of raltegravir in patients with haemophilia and anti-HIV multidrug resistance
pp. 108-111(4)
Authors: MANGIAFICO, L.; PERJA, M.; FUSCO, F.; RIVA, S.; MAGO, D.; GRINGERI, A.

C1272F: a novel type 2A von Willebrand's disease mutation in A1 domain; its clinical significance
pp. 112-116(5)
Authors: WOODS, A. I.; SANCHEZ-LUCEROS, A.; KEMPFER, A. C.; POWAZNIAK, Y.; CALDERAZZO PEREYRA, J. C.; BLANCO, A. N.; MESCHENGIESER, S. S.; LAZZARI, M. A.

Thrombocytopenia and bleeding in dental procedures of patients with Gaucher disease
pp. 117-121(5)
Authors: GIVOL, N.; GOLDSTEIN, G.; PELEG, O.; SHENKMAN, B.; ZIMRAN, A.; ELSTEIN, D.; KENET, G.

Attitudes of haemophilic patients towards their health and socio-economic problems in Iran
pp. 122-128(7)
Authors: MEHRAMIRI, A.; PARAND, S.; HAGHPANAH, S.; KARIMI, M.

Molecular diagnosis of haemophilia A at Centro Hospitalar de Coimbra in Portugal: study of 103 families - 15 new mutations
pp. 129-138(10)
Authors: SILVA PINTO, C.; FIDALGO, T.; SALVADO, R.; MARQUES, D.; GONÇALVES, E.; MARTINHO, P.; MARKOFF, A.; MARTINS, N.; LETÍCIA RIBEIRO, M.

Pharmacokinetics and pharmacodynamics of a new recombinant FVIII (N8) in haemophilia A mice
pp. 139-145(7)
Authors: ELM, T.; KARPF, D. M.; ØVLISEN, K.; PELZER, H.; EZBAN, M.; KJALKE, M.; TRANHOLM, M.